Antipentylenetetrazol action of clobazam in developing rats

Physiological Research

Volumn 48, Issue 6, 1999, Pages 501-507

  Haugvicova R ^a   Kubova H ^a   Mares P ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Anticonvulsant action; Clobazam; Ontogeny; Pentylenetetrazol; Rat; Seizures

Indexed keywords

CLOBAZAM; PENTETRAZOLE;

ADOLESCENT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; MALE; NEWBORN; NONHUMAN; RAT; SCORING SYSTEM; SEIZURE;

AGE FACTORS; ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BENZODIAZEPINES; BRAIN; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY, GENERALIZED; MALE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; SEIZURES;

EID: 0033398578     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. BRAESTRUP C, NIELSEN M: Ontogenetic development of benzodiazepine receptors in the rat brain. Brain Res 147: 170-173, 1978.
2. BROWNING RA: Role of brain-stem reticular formation in tonic-clonic seizures: lesion and pharmacologic studies. Fed Proc 44: 2425-2431, 1985.
3. BROWNING RA, NELSON DK: Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections. Exp Neurol 93: 546-556, 1986.
4. CACCIA S, GUISO G, GARATTINI S: Brain concentrations of clobazam and N-desmethylclobazam and antileptazol activity. J Pharm Pharmacol 32: 295-296, 1980a.
5. CACCIA S, GUISO G, SAMANIN R, GARATTINI S: Species differences in clobazam metabolism and antileptazol effect. J Pharm Pharmacol 32: 101-103, 1980b.
6. CANDY JM, MARTIN IL: The postnatal development of benzodiazepine receptor in the cerebral cortex and cerebellum of the rat. J Neurochem 32: 655-658, 1979.
7. DEPOORTERE H, ZIVKOVIC B, LLOYD KG, SANGER DJ, PERRAULT G, LANGER SZ, BARTHOLINI G: Zolpidem, a novel non-benzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 237: 649-658, 1986.
8. FIELDING S, HOFFMANN I: Pharmacology of anti-anxiety drugs with special reference to clobazam. Br J Clin Pharmacol 7: 7S-15S, 1979.
9. FISCHER RS, BLUM D: Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs. Epilepsia 36 (Suppl 2): S105-S114, 1995.
10. HAEFELY W: Benzodiazepines: mechanism of action. In: Antiepileptic Drugs. Third Edition. RH LEVY, FE DREIFUSS, RH MATTSON, BS MELDRUM, JK PENRY (eds), Raven Press, New York, 1989, pp 721-734.
11. HAEFELY W, MARTIN JR, SCHOCH P: Novel anxiolytics that act as partial agonists at benzodiazepine receptors. Trend Pharmacol Sci 11: 452-456, 1990.
12. HOOGERKAMP A, ARENDS RH, BOMERS AM, MANDEMA JW, VOSKUYL RA, DANHOF M: Pharmacokinetic/pharmacodynamic relationship of benzodiazepines in the direct cortical stimulation model of anticonvulsant effect. J Pharmacol Exp Ther 279: 803-812, 1996.
13. KLEPNER CA, LIPPA AS, BENSON DI, SANO MC, BEER B: Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol Biochem Behav 11: 457-462, 1979.
14. KUBOVÁ H, MAREŠ P: Time course of the anticonvulsant action of clonazepam during ontogenesis in the rat. Arch Int Pharmacodyn Ther 298: 15-24, 1989.
15. KUBOVÁ H, MAREŠ P: The effect of ontogenetic development on the anticonvulsant activity of midazolam. Life Sci 50: 1655-1672, 1992.
16. KUBOVÁ H, HAUGVICOVÁ R, MAREŠ P: Anticonvulsant effect of SL 75 102 in adult and immature rats. Physiol Res 46: 73-76, 1997.
17. LIPPA AS, BEER B, SANO M, VOGEL RA, MEYERSON LR: Differential ontogeny of type 1 and type 2 benzodiazepine receptors. Life Sci 28: 2343-2347, 1981.
18. LÖSCHER W, SCHMIDT D: Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2: 145-181, 1988.
19. LÖSCHER W, HÖNACK D, FASSBENDER CP, NOLTING B: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res 8: 171-189, 1991.
20. MACDONALD RL: Benzodiazepines: Mechanisms of action. In: Antiepileptic Drugs. Fourth Edition. RH LÉVY, RH MATTSON, BS MELDRUM (eds), Raven Press, New York, 1995, pp 695-703.
21. MAREŠ P, ZOUHAR A: Do we posses adequate models of childhood epilepsies? Physiol Bohemoslov 37: 1-9, 1988.
22. MAREŠ P, LANŠTIAKOVÁ M, VAŇKOVÁ S, KUBOVÁ H, VELÍŠEK L: Ketamine blocks cortical epileptic afterdischarges but not paired-pulse and frequency potentiation. Neuroscience 50: 339-344, 1992.
23. MAREŠ P, KUBOVÁ H, MOCKOVÁ M: Two models of epileptic spike-and-wave rhythm in rats are differently influenced by ethosuximide. Physiol Res 46: 397-402, 1997.
24. MULLER WE, GROH B, BUB O, HOFMANN HP, KREISKOTT H: In vitro and in vivo studies of the mechanism of action of arfendazam, a novel 1,5-benzodiazepine. Pharmacopsychiatry 19: 314-315, 1986.
25. MUNN R, CAMFIELD P, CAMFIELD C, DOOLEY J: Clobazam for refractory childhood seizure disorders - a valuable supplementary drug. Can J Neurol Sci 15: 406-408, 1988.
26. POHL M, MAREŠ P: Flunarizine influences metrazol-induced seizures in developing rats. Epilepsy Res 1: 302-305, 1987.
27. POLÁŠEK R, KUBOVÁ H, ŠLAMBEROVÁ R, MAREŠ P, VORLÍČEK J: Suppression of cortical epileptic afterdischarges in developing rats by anticonvulsants increasing GABAergic inhibition. Epilepsy Res 25: 177-184, 1996.
28. SHENOY AK, MIYAHARA JT, SWINYARD EA, KUPFERBERG HJ: Comparative anticonvulsant activity and neurotoxicity of clobazam, diazepam, phenobarbital, and valproate in mice and rats. Epilepsia 23: 399-408, 1982.
29. SHETH RD, RONEN GM, GOULDEN KJ, PENNY S, BODENSTEINER JB: Clobazam for intractable pediatric epilepsy. J Child Neurol 10: 205-208, 1995.
30. SHORVON SD. Benzodiazepines: clobazam. In: Antiepileptic Drugs. Fourth Edition. RH LÉVY, RH MATTSON, BS MELDRUM (eds), Raven Press, New York, 1995, pp 763-777.
31. ŠLAMBEROVÁ R, MAREŠ P, VORLÍČEK J: Clobazam exerts an anticonvulsant action in immature rats. Physiol Res 47: 301-305, 1998.
32. STAŇKOVÁ L, KOŽUCHOVÁ A, MAREŠ P: Anticonvulsant effect of progabide in rats during ontogenesis. Physiol Res 46: 47-52, 1997.
33. STERIADE M, DESCHENES M: The thalamus as a neuronal oscillator. Brain Res Rev 8: 1-62, 1984.
34. SWINYARD EA: Assay of antiepileptic drug activity in experimental animals: standard tests. In: Antiepileptic Drugs, Vol 1, J MERCIER (ed), Int Encycl Pharmacol Ther, Sect 19, Pergamon Press, Oxford, 1973, pp 47-65.
35. VELÍŠEK L, MIKOLÁŠOVÁ R, BLANKOVÁ-VAŇKOVÁ S, MAREŠ P: Effects of ketamine on metrazol-induced seizures during ontogenesis in rats. Pharmacol Biochem Behav 32: 405-410, 1989.
36. VELÍŠEK L, KUBOVÁ H, POHL M, STAŇKOVÁ L, MAREŠ P, SCHICKEROVÁ R: Pentylenetetrazol-induced seizures in rats: an ontogenetic study Naunyn-Schmiedeberg's Arch Pharmacol 346: 588-591, 1992.